Mr Bruce D Polly, RPH | |
53 Queendale Ctr, Beverly, KY 40913-9608 | |
(606) 598-3186 | |
(606) 598-7788 |
Full Name | Mr Bruce D Polly |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 53 Queendale Ctr, Beverly, Kentucky |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053421560 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 010109 (Kentucky) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Bruce D Polly, RPH 3733 Kenesaw Dr, Lexington, KY 40515-1217 Ph: (859) 271-0133 | Mr Bruce D Polly, RPH 53 Queendale Ctr, Beverly, KY 40913-9608 Ph: (606) 598-3186 |
News Archive
Virginia Commonwealth University's School of Medicine has been ranked fourth among federally funded U.S. universities based on the average number of citations per research paper published in indexed journals of gastroenterology and hepatology between 1999 and 2003.
When Jerry Jewler turned 60, he celebrated his "coming of age" with a splashy party - and a glorious high. The next day, he awoke to a hell he had never known: sad and depressed, unable to make even idle chatter with his houseguests, and angry at the world.
Dr. Paul Sanberg, Distinguished University Professor and senior associate vice president for research and innovation at the University of South Florida, received the Everfront Award at the 4th Pan Pacific Symposium on Stem Cell and Cancer Research held earlier this month in Taichung, Taiwan.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular diseases, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its U.S. Patent Application Number 11/226,908 entitled "Methods for Treatment with Bucindolol Based on Genetic Targeting." The Notice of Allowance is the USPTO's official communication that the examination of the patent application has been successfully completed and that a patent will be issued.
Drug-resistant HIV viruses can spread rapidly. This is the conclusion of a study conducted as part of the SWISS HIV Cohort Study, which is supported by the SNSF. Only the continuous introduction of new drugs can stop the virus from getting the upper hand.
› Verified 1 days ago